Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
43,92 USD | +10,97% |
|
+13,17% | +53,14% |
Attività
Numero di dipendenti: 411
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Targeted Therapies
100,0
%
| 35 | 100,0 % | 12 | 100,0 % | -67,27% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 35 | 100,0 % | 12 | 100,0 % | -67,27% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 01/10/14 |
Jack Anders
DFI | Director of Finance/CFO | 47 | 01/08/18 |
Wally Reiher
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/15 |
Wei Lin
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/04/23 |
Steve Kelsey
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/03/17 |
Peg Horn
COO | Chief Operating Officer | 61 | - |
Linnet Zia
PRN | Corporate Officer/Principal | - | 01/03/19 |
Jeff Cislini
LAW | General Counsel | 49 | 01/01/20 |
Daniel Simon
PRN | Corporate Officer/Principal | - | 01/09/22 |
Xiao Lin Wang
PRN | Corporate Officer/Principal | 53 | 01/03/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 01/10/14 |
Alexis Borisy
BRD | Director/Board Member | 52 | 01/11/14 |
Sandra Horning
BRD | Director/Board Member | 75 | 09/11 |
Barbara Weber
BRD | Director/Board Member | 67 | 01/04/18 |
Thilo Schroeder
BRD | Director/Board Member | 42 | 01/03/18 |
Lorence Kim
BRD | Director/Board Member | 49 | 12/07/22 |
Director/Board Member | 66 | 01/03/15 | |
Flavia Borellini
BRD | Director/Board Member | 65 | 22/06/21 |
Sushil Patel
BRD | Director/Board Member | 52 | 16/06/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 170 546 280 | 160 428 872 ( 94,07 %) | 5 560 053 ( 3,260 %) | 94,07 % |
Coordinate società
![Indirizzo Revolution Medicines, Inc.(RVMD)](https://cdn.zonebourse.com/static/address/102616325.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+53,14% | 6,53 Mrd | |
+16,71% | 44,63 Mrd | |
+42,66% | 40,46 Mrd | |
-7,92% | 38,07 Mrd | |
+33,09% | 32,27 Mrd | |
-7,10% | 27,3 Mrd | |
+14,46% | 26,53 Mrd | |
+46,73% | 14,06 Mrd | |
+34,07% | 12,54 Mrd | |
-7,61% | 11,28 Mrd |
- Borsa valori
- Azioni
- Azione RVMD
- Società Revolution Medicines, Inc.